Skip to main content

Peer Review reports

From: Antimelanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis: clinical features and outcomes in a racially diverse patient cohort

Original Submission
13 Sep 2024 Submitted Original manuscript
27 Sep 2024 Author responded Author comments - Fatema Ezzy
Resubmission - Version 2
27 Sep 2024 Submitted Manuscript version 2
8 Oct 2024 Author responded Author comments - Fatema Ezzy
Resubmission - Version 3
8 Oct 2024 Submitted Manuscript version 3
20 Oct 2024 Reviewed Reviewer Report
24 Oct 2024 Reviewed Reviewer Report
21 Nov 2024 Author responded Author comments - Fatema Ezzy
Resubmission - Version 4
21 Nov 2024 Submitted Manuscript version 4
28 Nov 2024 Reviewed Reviewer Report
29 Nov 2024 Reviewed Reviewer Report
14 Dec 2024 Author responded Author comments - Fatema Ezzy
Resubmission - Version 5
14 Dec 2024 Submitted Manuscript version 5
20 Dec 2024 Author responded Author comments - Fatema Ezzy
Resubmission - Version 6
20 Dec 2024 Submitted Manuscript version 6
Publishing
1 Jan 2025 Editorially accepted
9 Jan 2025 Article published 10.1186/s41927-025-00455-5

You can find further information about peer review here.

Back to article page